Published in J Vasc Interv Radiol on September 01, 2005
Re: The American "board" of vascular medicine: questions and concerns. J Vasc Interv Radiol (2006) 0.75
Re: The American "board" of vascular medicine: questions and concerns. J Vasc Interv Radiol (2006) 0.75
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke (2003) 7.75
In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science (2008) 5.09
CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med (2007) 4.66
Phagosomes are competent organelles for antigen cross-presentation. Nature (2003) 3.97
Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol (2003) 3.62
Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology (2005) 3.51
Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med (2007) 2.75
Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood (2003) 2.65
Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med (2004) 2.57
Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference. J Vasc Interv Radiol (2006) 2.32
Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 2.29
Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol (2007) 2.23
Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol (2006) 2.22
CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J Immunol (2002) 2.16
Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies. Proc Natl Acad Sci U S A (2008) 1.98
Radiation doses in interventional radiology procedures: the RAD-IR study: part I: overall measures of dose. J Vasc Interv Radiol (2003) 1.95
Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2005) 1.89
Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol (2002) 1.75
Genetic characterization of glucose transporter function in Leishmania mexicana. Proc Natl Acad Sci U S A (2003) 1.64
The IR RadLex project: an interventional radiology lexicon--a collaborative project of the Radiological Society of North America and the Society of Interventional Radiology. J Vasc Interv Radiol (2008) 1.61
Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev (2006) 1.61
Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc Natl Acad Sci U S A (2006) 1.58
Guidelines for patient radiation dose management. J Vasc Interv Radiol (2009) 1.56
Global statement defining interventional radiology. J Vasc Interv Radiol (2010) 1.54
Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. Cardiovasc Intervent Radiol (2004) 1.48
Quality improvement guidelines for percutaneous transhepatic cholangiography and biliary drainage. J Vasc Interv Radiol (2003) 1.48
IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J Immunol (2009) 1.46
IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J Immunol (2011) 1.44
Training guidelines for intra-arterial catheter-directed treatment of acute ischemic stroke: a statement from a special writing group of the Society of Interventional Radiology. J Vasc Interv Radiol (2009) 1.42
Denied in Canada: why we need a global strategic plan for interventional radiology. J Vasc Interv Radiol (2008) 1.41
Retrieval of inferior vena cava filters after prolonged indwelling time. Arch Intern Med (2011) 1.40
Conflicts of interest in the development of new interventional medical devices. J Vasc Interv Radiol (2009) 1.39
Quality improvement guidelines for percutaneous nephrostomy. J Vasc Interv Radiol (2003) 1.37
Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol (2003) 1.37
Radiation doses in interventional radiology procedures: the RAD-IR study: part II: skin dose. J Vasc Interv Radiol (2003) 1.37
Society of Interventional Radiology quality improvement guidelines for percutaneous vertebroplasty. J Vasc Interv Radiol (2003) 1.34
IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis (2011) 1.33
Quality improvement guidelines for percutaneous needle biopsy. J Vasc Interv Radiol (2010) 1.33
Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis. J Immunol (2009) 1.29
Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. J Vasc Interv Radiol (2003) 1.27
Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol (2009) 1.27
Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol (2010) 1.25
Occupational radiation protection in interventional radiology: a joint guideline of the Cardiovascular and Interventional Radiology Society of Europe and the Society of Interventional Radiology. Cardiovasc Intervent Radiol (2009) 1.24
Quality improvement guidelines for percutaneous management of the thrombosed or dysfunctional dialysis access. J Vasc Interv Radiol (2003) 1.23
Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. J Immunol (2006) 1.22
Optimization of DNA vaccination against cutaneous leishmaniasis. Vaccine (2002) 1.22
Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clin Vaccine Immunol (2012) 1.20
Occupational radiation protection in interventional radiology: a joint guideline of the Cardiovascular and Interventional Radiology Society of Europe and the Society of Interventional Radiology. J Vasc Interv Radiol (2010) 1.20
Reporting standards for central venous access. J Vasc Interv Radiol (2003) 1.18
Reporting standards for percutaneous interventions in dialysis access. J Vasc Interv Radiol (2003) 1.17
Quality improvement guidelines for percutaneous transcatheter embolization: Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol (2010) 1.17
SIR reporting standards for the treatment of acute limb ischemia with use of transluminal removal of arterial thrombus. J Vasc Interv Radiol (2003) 1.16
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2007) 1.16
IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice. J Immunol (2008) 1.16
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 1.16
Society of Interventional Radiology quality improvement guidelines for percutaneous vertebroplasty. J Vasc Interv Radiol (2003) 1.15
Clinical practice of interventional and cardiovascular radiology: current status, guidelines for resource allocation, future directions. J Am Coll Radiol (2004) 1.13
Evaluation of blood agar microtiter plates for culturing leishmania parasites to titrate parasite burden in spleen and peripheral blood of patients with visceral leishmaniasis. J Clin Microbiol (2010) 1.13
Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation (2002) 1.12
Radiation doses in interventional radiology procedures: the RAD-IR Study. Part III: Dosimetric performance of the interventional fluoroscopy units. J Vasc Interv Radiol (2004) 1.12
Quality improvement in radiology: white paper report of the Sun Valley Group meeting. J Am Coll Radiol (2006) 1.12
Quality improvement guidelines for percutaneous permanent inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol (2003) 1.12
Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol (2006) 1.10
Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect Immun (2002) 1.08
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol (2006) 1.08